Reader View AI Reader View Sanofi to pay Regeneron up to $8 billion to add new antibodies under Dupixent partnership www.investing.com · October 1, 2026 · 07:26 Paywall detected This article has a paywall The publisher blocks direct access to this article. Generate with AI Open link